1. Home
  2. IHS vs AORT Comparison

IHS vs AORT Comparison

Compare IHS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IHS Holding Limited

IHS

IHS Holding Limited

HOLD

Current Price

$8.11

Market Cap

2.5B

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$37.24

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHS
AORT
Founded
2001
1984
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
IHS
AORT
Price
$8.11
$37.24
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$8.11
$48.76
AVG Volume (30 Days)
2.8M
477.8K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.62
EPS
N/A
0.21
Revenue
N/A
$298,836,000.00
Revenue This Year
$3.90
$14.20
Revenue Next Year
$2.59
$11.17
P/E Ratio
$5.85
$179.67
Revenue Growth
N/A
18.01
52 Week Low
$3.41
$21.97
52 Week High
$8.95
$48.25

Technical Indicators

Market Signals
Indicator
IHS
AORT
Relative Strength Index (RSI) 53.55 40.04
Support Level $7.78 $34.35
Resistance Level $8.21 $44.29
Average True Range (ATR) 0.12 1.51
MACD -0.02 0.23
Stochastic Oscillator 56.82 61.54

Price Performance

Historical Comparison
IHS
AORT

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: